Compound ID | 2112

Halicin

Synonym(s): EN-7  |  SU-3327  |  SU3327

Class: Thiadiazole

Spectrum of activity: Gram-positive  &  Gram-negative
Details of activity: Disrupts the maintainance of an electrochemical gradient across the membrane. Activity against E. coli, Acinetobacter and Mycobacterium tuberculosis
Description: Synthetic compound; repurposed c-Jun N-terminal kinase inhibitor SU3327 (diabetic treatment) through machine learning modeling and experimental design.
Year first mentioned: 2019
Development status: Experimental
Chemical structure(s):
Canonical SMILES: C1=C([N+](=O)[O-])SC(=N1)SC2=NN=C(N)S2
Isomeric SMILES: C1=C(SC(=N1)SC2=NN=C(S2)N)[N+](=O)[O-]
InChI: InChI=1S/C5H3N5O2S3/c6-3-8-9-5(14-3)15-4-7-1-2(13-4)10(11)12/h1H,(H2,6,8)
InChI Key: NQQBNZBOOHHVQP-UHFFFAOYSA-N
Structure link: https://pubchem.ncbi.nlm.nih.gov/compound/11837140
External links:
Main Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349178/
Citations:
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698312/
  • https://www.sciencedirect.com/science/article/pii/S2666246922000076
  • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us.

    Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.